Sort
53,477 grants matching “addiction”
Overcoming Tramadol Resistance In CYP2D6 Poor Metabolizers
$649,545Stuart J Kahn · Syntrix Biosystems, Inc. · R43 · FY2010 · DA
Employment-Based Depot Naltrexone Clinical Trial
$649,496Kenneth Silverman · Johns Hopkins University · R01 · FY2006 · DA
Assessing the Impact of Cannabis Legalization on Adolescent Cannabis Use and Cannabis-Related Health Conditions
$649,431Kelly Corinne Young-Wolff · Kaiser Foundation Research Institute · R01 · FY2025 · DA
PP2A ACTIVATION AS A THERAPY FOR AR ADDICTED REFRACTORY CASTRATION-RESISTANT PROSTATE CANCER.
$649,303Trustees Of The University Of Pennsylvania, The · · FY2021 · Defense Health Agency
Translational Studies of Prefrontal Control of Fear Extinction
$649,292Gregory J. Quirk · University Of Puerto Rico Med Sciences · R01 · FY2010 · MH
Signal Transduction by Tyrosine Phosphorylation
$649,169Tony R. Hunter · Salk Institute For Biological Studies · R01 · FY2014 · CA
Genetics of Adolescent Antisocial Drug Dependence
$649,070John K Hewitt · University Of Colorado · R01 · FY2012 · DA
Alcohol Stimulation and Sedation in Binge Drinkers - Renewal 01
$649,011Andrea C King · University Of Chicago · R01 · FY2019 · AA
Substance Disorders, Substance Use Treatment, and Sexual Orientation in Youth
$648,965Heather L. Corliss · Brigham And Women'S Hospital · R01 · FY2017 · DA
Receptor Profiling and Compound Library Screening
$648,912Novascreen Biosciences Corporation · N01 · FY2012 · DA
Improving outcomes for substance-affected families in the child welfare system
$648,897Stephen W Patrick · Vanderbilt University Medical Center · R01 · FY2023 · DA
Plasticity of Aversive Salience in Opioid Use Disorder
$648,878Jennifer Lorraine Stewart · Laureate Institute For Brain Research · R01 · FY2021 · DA
Characterization of Tandem Repeat and Structural Variants Contributing to Addictive Behaviors in Mice and Rats
$648,766Abraham A Palmer · University Of California, San Diego · U01 · FY2024 · DA
Reducing Overdose and Suicide Risk in Individuals with OUD and Co-occurring Disorders
$648,635Katherine E Watkins · Rand Corporation · R01 · FY2023 · DA
Brain Morbidity in Treatment-Naive Alcoholics
$648,583George Fein · Neurobehavioral Research, Inc. · R01 · FY2010 · AA
Developmental Core
$648,571Herman F. Staats · Duke University · P30 · FY2024 · AI
Beyond characterizing flavors: Effects of odorless constituents (sensory additives, solvents, and synthetic nicotine) on tobacco product use behaviors from adolescence to adulthood
$648,571Nii Addy · Yale University · U54 · FY2024 · DA
RCMI Community Engagement Core
$648,543Lorraine R. Reitzel · University Of Houston · U54 · FY2022 · MD
Modeling Physiology and Behavior of Veterans to Avert Opioid Related Mortality Through Timely Intervention
$648,512Ellie Gordon · Behaivior Inc. · R44 · FY2025 · DA
Maternal Opioid Treatment: Human Experimental Research
$648,500Karol Kaltenbach · Thomas Jefferson University · R01 · FY2008 · DA
A118G SNP and OPRM1 Gene Opioid-Mediated Effects in Humans
$648,482Kelly E Dunn · Johns Hopkins University · R01 · FY2016 · DA
Learning Theory to Improve Obesity Treatments
$648,457Kerri N Boutelle · University Of California, San Diego · R01 · FY2012 · DK
Risk for opioid abuse and misuse in adolescence
$648,453Anna Camille Wilson · Oregon Health & Science University · R01 · FY2022 · DA
Neurotoxicity in the adult rat following chronic exposure to methamphetamine
$648,434Jean Lud Cadet · National Institute On Drug Abuse · ZIA · FY2009 · DA
Methamphetamine Administration Causes Death of Dopaminergic Neurons in the Mouse
$648,434Jean Lud Cadet · National Institute On Drug Abuse · ZIA · FY2009 · DA